Pricing Log in Create free account

GlucoTrack, Inc. (GCTK) vs Nexalin Technology, Inc. (NXL)

GlucoTrack, Inc. and Nexalin Technology, Inc. are both Medical Devices companies. GlucoTrack, Inc. and Nexalin Technology, Inc. are of similar size ($1.7M and $1.6M). Nexalin Technology, Inc. grew revenue faster over the last twelve months: 24.3% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −4,138.5%) and the higher return on invested capital (0.00% vs −1,108.8%). Across the 17 metrics below, GlucoTrack, Inc. leads on 9 and Nexalin Technology, Inc. on 8.

Valuation

Metric GCTK NXL Medical Devices median
P/E n/m n/m 24.94
P/S 0.24 4.54 2.66
P/B n/m 0.65 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m 0.00 11.42
EV/Sales 4.16 (0.06) 2.76
Earnings yield (100,122.63%) (1,029.60%) (12.66%)
Free cash flow yield (32,549.37%) (642.95%) (7.18%)

Profitability

Metric GCTK NXL Medical Devices median
Gross margin 0.00% 86.14% 57.76%
Operating margin 0.00% (4,201.66%) (14.84%)
Net margin 0.00% (4,138.49%) (14.45%)
Free cash flow margin 0.00% (2,917.96%) (5.70%)
Return on equity (620.63%) (240.25%) (10.56%)
Return on assets (272.48%) (187.89%) (17.26%)
Return on invested capital 0.00% (1,108.82%) (5.22%)

Growth

Metric GCTK NXL Medical Devices median
Revenue growth (TTM) (60.61%) 24.26% 10.41%
EPS growth (last fiscal year) 99.17% 39.76% 28.17%
Revenue growth, 5-year CAGR 28.31% 4.42% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GCTK NXL Medical Devices median
Debt to equity (1.11) 0.00 0.04
Current ratio 0.46 1.25 2.67
Net debt to EBITDA 0.25 0.44 0.54

Dividend

Metric GCTK NXL Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric GCTK NXL Medical Devices median
Market cap 1.65m 1.61m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack